The risk is particularly negligible in prepubertal years [20]
Important Note on the Evidence Base Important note on the evidence base: The published research on BPC-157 consists predominantly of animal-model studies (primarily rats) and in vitro cell-culture experiments
The primary concern relates to their cumulative effects on the gastrointestinal tract and the potential for increased adverse events
People who add collagen to their routine report not only increased skin elasticity but also faster nail growth and significant improvements in reducing brittleness
Chris Serres: And Obviously, you know, theres a huge public interest in this
Phase 1b/2a Subcutaneous Formulation (Obesity) Published: The Lancet, June 2025 Participants: 125 adults with overweight or obesity (BMI 27.039.9), aged 1855 Duration: Up to 36 weeks Dosing: Once-weekly subcutaneous amycretin, up to 60 mg Results: - Up to 22% absolute weight loss at 36 weeks (highest dose group) - Placebo-adjusted difference: approximately 24% - No weight-loss plateau observed at study end Safety: 81% of the 89 participants who reported a TEAE had gastrointestinal events